These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting. Callis Duffin K; Gottlieb AB; Merola JF; Latella J; Garg A; Armstrong AW J Rheumatol; 2017 May; 44(5):701-702. PubMed ID: 28461532 [TBL] [Abstract][Full Text] [Related]
48. [Alginates as keratolytic agents in local dermatological therapy]. De Luca M Minerva Dermatol; 1968 Mar; 43(3):135-7. PubMed ID: 5740427 [No Abstract] [Full Text] [Related]
50. Polyphenotypic Psoriasis: A Report from the GRAPPA 2016 Annual Meeting. Kaskas N; Merola JF; Qureshi AA; Paek SY J Rheumatol; 2017 May; 44(5):695-696. PubMed ID: 28461530 [TBL] [Abstract][Full Text] [Related]
51. Molecular mechanisms of tazarotene action in psoriasis. Duvic M; Nagpal S; Asano AT; Chandraratna RA J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552 [TBL] [Abstract][Full Text] [Related]
52. Psoriasis Therapy: Breakthroughs in Pharmacogenomics or in Pharmacology? Lebwohl M J Invest Dermatol; 2016 Dec; 136(12):2339-2340. PubMed ID: 27884289 [TBL] [Abstract][Full Text] [Related]
53. Tumor necrosis factor (TNF) inhibitors revolutionalized therapy for both psoriasis and psoriatic arthritis. Foreword. Gottlieb AB Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S3-4. PubMed ID: 24777570 [No Abstract] [Full Text] [Related]
54. [What's new in dermatological research? Contributions from the 2006 literature]. Caux F Ann Dermatol Venereol; 2007 Dec; 134 Suppl 1():8S16-23. PubMed ID: 18675137 [TBL] [Abstract][Full Text] [Related]
55. Effect of mycophenolate mofetil therapy on the phenotypic profile of peripheral blood leukocyte populations in psoriatic patients. Daudén E; Pedraz J; Pérez-Gala S; Muñoz C; Vitón M; Onate MJ; García-Díez A Eur J Dermatol; 2010; 20(2):233-4. PubMed ID: 20007061 [No Abstract] [Full Text] [Related]
57. [Dermatology--new therapeutic possibilities. The Danish Society of Dermatology]. Gniadecki R; Haedersdal M Ugeskr Laeger; 2006 Mar; 168(12):1213. PubMed ID: 16571304 [No Abstract] [Full Text] [Related]
58. Methotrexate: new therapeutic approaches. Puig L Actas Dermosifiliogr; 2014; 105(6):583-9. PubMed ID: 23434058 [TBL] [Abstract][Full Text] [Related]
59. [How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate]. Henry F; Flagothier C; Piérard-Franchimont C; Piérard GE Rev Med Liege; 2006 Mar; 61(3):139-41. PubMed ID: 16680996 [TBL] [Abstract][Full Text] [Related]
60. Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol. Liu X; Liu Y; Xu M; Li J; Teng X; Cheng H; Xia Y Br J Dermatol; 2016 Aug; 175(2):314-24. PubMed ID: 26875609 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]